Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INARI MEDICAL, INC.

(NARI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Outlasting Declining Biotechs

11/10/2021 | 03:57pm EST


ę MT Newswires 2021
All news about INARI MEDICAL, INC.
01/12Inari Medical to Seek Acquisitions
CI
01/11Inari Medical Expects Double-Digit Growth in Q4, 2021 Revenue -- Shares Jump in Pre-Mar..
MT
01/10INARI MEDICAL : Reports Preliminary Fourth Quarter 2021 Revenue - Form 8-K
PU
01/10Inari Medical Expects Double-Digit Growth in Q4, 2021 Revenue; Shares Soar After-Hours
MT
01/10Inari Medical Reports Preliminary Fourth Quarter 2021 Revenue
AQ
01/10Inari Medical, Inc. Provides Preliminary Unaudited Revenue Guidance for the Fourth Quar..
CI
01/07INSIDER SELL : Inari Medical
MT
2021Inari Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021INSIDER SELL : Inari Medical
MT
2021INSIDER SELL : Inari Medical
MT
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2021 272 M - -
Net income 2021 7,86 M - -
Net cash 2021 173 M - -
P/E ratio 2021 411x
Yield 2021 -
Capitalization 3 769 M 3 769 M -
EV / Sales 2021 13,2x
EV / Sales 2022 10,6x
Nbr of Employees 456
Free-Float -
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 75,07 $
Average target price 121,00 $
Spread / Average Target 61,2%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-17.75%3 769
MASIMO CORPORATION-20.39%12 350
GETINGE AB-16.35%9 870
PENUMBRA, INC.-22.13%8 358
NOVOCURE LIMITED-14.21%6 687
SHOCKWAVE MEDICAL, INC.-12.50%5 509